Announcements
Projects
Orgs
Project
Lilly.com

Interested in joining Lilly.com?

Create your account and become part of this amazing organization. Start collaborating, sharing ideas, and building connections today!

Join Lilly.com Sign In First
Articles
4
Lilly's orforglipron helped people maintain weight loss after switching from injectable incretins to oral GLP-1 therapy in first-of-its-kind Phase 3 trial - Eli Lilly
2d
FDA Approves Lilly's Omvoh™ (mirikizumab-mrkz), A First-in-Class Treatment for Adults with Moderately to Severely Active Ulcerative Colitis | Eli Lilly and Company - Investors | Eli Lilly and Company
~2y
Lilly to Acquire DICE Therapeutics to Advance Innovation in Immunology | Eli Lilly and Company - Investors | Eli Lilly and Company
>2y
Lilly's Donanemab Significantly Slowed Cognitive and Functional Decline in Phase 3 Study of Early Alzheimer's Disease | Eli Lilly and Company - Investors | Eli Lilly and Company
>2y